Clinical Trial Update: Combination Therapy for Age-Related Macular Degeneration. [Phase 2]

View source ↗

Summary

Phase 2 trial update for a combination therapy in age-related macular degeneration shows the study has completed enrollment. The status is listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Age Related Macular Degeneration | Phase 2 | Status: COMPLETED